Associations of Thrombotic-Hemostatic Factors with Cardiovascular Disease~!2009-10-29~!2009-12-22~!2010-04-08~!

No abstract is available for this paper.

• Publication year

  2010

• Venue

  The Open Clinical Chemistry Journal

• Publication date

  2010-04-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1874241601003010025
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Sentinel Surveillance of Influenza-Like-Illness in Two Cities of the Tropical Country of Ecuador: 2006–2010

  2011cited by this paper
• Homocysteine,MTHFR gene polymorphisms, and cardio-cerebrovascular risk

  2010cited by this paper
• Homocysteine-Lowering Therapy and Stroke Risk, Severity, and Disability: Additional Findings From the HOPE 2 Trial

  2009cited by this paper
• FACTOR VII-PHOSPHOLIPID COMPLEX IN MALE SURVIVIRS OF ACUTE MYCORDIAL INFARCTION

  2009cited by this paper
• Oxidized LDL, lipoprotein (a) and other emergent risk factors in acute myocardial infarction (FORTIAM study).

  2009cited by this paper
• Homocystinuria, arteriosclerosis, methylmalonic aciduria, and methyltransferase deficiency: a key case revisited.

  2009cited by this paper
• Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA Study.

  2009cited by this paper
• [Lipoprotein (a) and stroke].

  2008influential reference
• Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.

  2008cited by this paper
• Von Willebrand Factor, Type 2 Diabetes Mellitus, and Risk of Cardiovascular Disease: The Framingham Offspring Study

  2008cited by this paper
• Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII).

  2008cited by this paper
• Simvastatin Reduces Circulating Plasminogen Activator Inhibitor 1 Activity in Volunteers with the Metabolic Syndrome

  2008cited by this paper
• Angiography : A Randomized Controlled Trial CoronaryWith Homocysteine-Lowering B Vitamins After Mortality and Cardiovascular Events in Patients Treated

  2008cited by this paper
• The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.

  2008cited by this paper
• Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.

  2008influential reference
• The role of fibrinogen and fibrinolysis in peripheral arterial disease.

  2008cited by this paper
• Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery

  2008cited by this paper
• Homocysteine, B-vitamins and CVD

  2008cited by this paper
• The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis

  2008cited by this paper
• Elevated Lp(a) with a small apo(a) isoform in children: risk factor for the development of premature coronary artery disease

  2008cited by this paper
• Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data.

  2008cited by this paper
• A Dynamic Comparative Study Concerning the Effects of Angiotensin-Converting Enzyme Inhibitors and Aldosterone Receptor Blockers on the Fibrinolytic System

  2008cited by this paper
• Homocysteine predicts adverse clinical outcomes in unstable angina and non-ST elevation myocardial infarction: implications from the folate intervention in non-ST elevation myocardial infarction and unstable angina study

  2008influential reference
• Efficacy of folic acid supplementation in stroke prevention: a meta-analysis.

  2007cited by this paper
• Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study.

  2007influential reference
• Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery.

  2007cited by this paper
• Non-traditional cardiovascular risk factors contribute to peripheral arterial disease in patients with type 2 diabetes.

  2007cited by this paper
• Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration.

  2007cited by this paper
• Plasma Homocysteine Levels and Late Outcome in Patients with Unstable Angina

  2007influential reference
• Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease

  2007cited by this paper
• Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation.

  2007cited by this paper
• The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways.

  2007cited by this paper
• Haemorheological, platelet and endothelial indices in relation to global measures of cardiovascular risk in hypertensive patients: a substudy of the Anglo‐Scandinavian Cardiac Outcomes Trial

  2007cited by this paper
• Metabolic disorders in patients with chronic kidney failure.

  2007cited by this paper
• Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and Stroke: The Edinburgh Artery Study

  2007cited by this paper
• Ankle—brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort

  2007cited by this paper
• Improvement in Stroke Mortality in Canada and the United States, 1990 to 2002

  2006cited by this paper
• Dyslipidaemia, hypercoagulability and the metabolic syndrome.

  2006cited by this paper
• [Homocysteine lowering with folic acid and B vitamins in vascular disease].

  2006cited by this paper
• Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials.

  2006cited by this paper
• Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients

  2006cited by this paper
• Effects of older age on fibrin D‐dimer, C‐reactive protein, and other hemostatic and inflammatory variables in men aged 60–79 years

  2006cited by this paper
• Coagulation and atherothrombotic disease.

  2006influential reference
• Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.

  2006cited by this paper
• Tissue Factor and Coagulation Factor VII Levels During Acute Myocardial Infarction: Association With Genotype and Adverse Events

  2006cited by this paper
• Serum homocysteine concentration as a marker of nutritional status of healthy subjects in Crete, Greece.

  2006cited by this paper
• von Willebrand factor, endothelial dysfunction, and cardiovascular disease

  2006influential reference
• Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.

  2006cited by this paper
• Prevalence and mechanisms of hyperhomocysteinemia in chronic alcoholics.

  2005cited by this paper
• Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.

  2005cited by this paper
• Mechanisms of homocysteine‐induced atherothrombosis

  2005cited by this paper
• Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.

  2005cited by this paper
• Homocysteine and methionine metabolism in renal failure.

  2005cited by this paper
• Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studies

  2005cited by this paper
• Effect of drugs on homocysteine concentrations.

  2005cited by this paper
• Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials.

  2005cited by this paper
• Fibrinogen and fibrin structure and functions

  2005cited by this paper
• Independent association of von Willebrand factor with surrogate markers of atherosclerosis in middle‐aged asymptomatic subjects

  2005cited by this paper
• Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

  2005cited by this paper
• Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke?: The Caerphilly Study

  2005cited by this paper
• Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.

  2005cited by this paper
• Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy.

  2005cited by this paper
• Conditional risk factors for atherosclerosis.

  2005cited by this paper
• Which Hemostatic Markers Add to the Predictive Value of Conventional Risk Factors for Coronary Heart Disease and Ischemic Stroke

  2005influential reference
• Overview of hemostatic factors involved in atherosclerotic cardiovascular disease

  2005cited by this paper
• Plasma von Willebrand factor and arterial aging

  2005cited by this paper
• Endothelial Cell Markers and the Risk of Coronary Heart Disease: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study

  2004cited by this paper
• Diet, serum homocysteine levels and ischaemic heart disease in a Mediterranean population.

  2004cited by this paper
• C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

  2004cited by this paper
• Association of Serum Total Homocysteine with the Extent of Ischemic Heart Disease in a Mediterranean Cohort

  2004cited by this paper
• Tissue plasminogen activator antigen and coronary heart disease

  2004cited by this paper
• Interleukin-6, Fibrin D-Dimer, and Coagulation Factors VII and XIIa in Prediction of Coronary Heart Disease

  2004cited by this paper
• Homocysteine Concentrations in Subclinical Hypothyroidism

  2004cited by this paper
• Homocysteine: is it a clinically important cardiovascular risk factor?

  2004cited by this paper
• The impact of third-generation beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: effects of smoking.

  2004cited by this paper
• Tissue plasminogen activator antigen and coronary heart disease Prospective study and meta-analysis

  2004cited by this paper
• Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study.

  2004cited by this paper
• C-Reactive Protein, Fibrin D-Dimer, and Risk of Ischemic Heart Disease: The Caerphilly and Speedwell Studies

  2004influential reference
• Effects of Statins on Nonlipid Serum Markers Associated with Cardiovascular Disease

  2003cited by this paper
• Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review.

  2003influential reference
• Peripheral artery disease in type 2 diabetes: the role of fibrinolysis

  2003cited by this paper
• Does sticky blood predict a sticky end? Associations of blood viscosity, haematocrit and fibrinogen with mortality in the West of Scotland

  2003cited by this paper
• Fibrinogen: biochemistry, epidemiology and determinants.

  2003influential reference
• Classical homocystinuria: Vascular risk and its prevention

  2003cited by this paper
• Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans

  2003cited by this paper
• C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease: The PRIME Study

  2003cited by this paper
• von Willebrand factor and coronary heart disease: prospective study and meta-analysis.

  2002cited by this paper
• Soluble Intercellular Adhesion Molecule-1 and Risk of Future Ischemic Stroke: A Nested Case-Control Study From the Bezafibrate Infarction Prevention (BIP) Study Cohort

  2002cited by this paper
• Elevated Fibrinogen and Homocysteine Levels Enhance the Risk of Mortality in Patients From a High-Risk Preventive Cardiology Clinic

  2002cited by this paper
• The Physiological Role of Lipoprotein (a).

  2002cited by this paper
• Angiotensin and vascular fibrinolytic balance.

  2002cited by this paper
• Reteplase: nursing implications for catheter-directed thrombolytic therapy for peripheral vascular occlusions.

  2002cited by this paper
• Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

  2002cited by this paper
• Age-Dependent Spontaneous Coronary Arterial Thrombosis in Transgenic Mice That Express a Stable Form of Human Plasminogen Activator Inhibitor-1

  2002cited by this paper
• Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

  2002cited by this paper
• Effect of combination glipizide GITS/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects.

  2002cited by this paper
• Initial clinical results of tenecteplase (TNK) in catheter-directed thrombolytic therapy.

  2002cited by this paper
• Vascular Outcome in Patients With Homocystinuria due to Cystathionine &bgr;-Synthase Deficiency Treated Chronically: A Multicenter Observational Study

  2001cited by this paper
• Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis

  2001cited by this paper
• Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.

  2001cited by this paper

• Development of an Impedimetric Immunosensor for D-Dimer Detection Using Reduced Graphene Oxide, Gold and Thionine Based Nanocomposite

  2025cites this paper
• Electrochemical Biosensor for Homocysteine Detection Using Poly‐L‐Lysine Coated Reduced Graphene Oxide Nanocomposite

  2025cites this paper
• Uji Aktivitas Fibrinolitik Jus Cacing Tanah (Lumbricus rubellus) Pada Tikus yang Diberi Asam Traneksamat

  2023cites this paper
• Production, characterization and optimization of fibrinolytic protease from Bacillus pseudomycoides strain MA02 isolated from poultry slaughter house soils

  2019cites this paper
• Food Origin Fibrinolytic Enzyme With Multiple Actions

  2017cites this paper
• A DESCRIPTIVE STUDY OF THE CONVENTIONAL AND NEW RISK FACTOR ANALYSIS IN PATIENTS WITH ISCHAEMIC HEART DISEASE

  2013cites this paper